BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10526548)

  • 21. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002209. PubMed ID: 12519570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Has the shift to managed care reduced Medicaid expenditures? Evidence from state and local-level mandates.
    Duggan M; Hayford T
    J Policy Anal Manage; 2013; 32(3):505-35. PubMed ID: 23814802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinton administration plans to expand access to methadone.
    McCarthy M
    Lancet; 1998 Oct; 352(9135):1206. PubMed ID: 9777853
    [No Abstract]   [Full Text] [Related]  

  • 27. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of public and private insurance enrollment among Medicaid-eligible children.
    Davidoff AJ; Garrett B
    Med Care; 2001 Jun; 39(6):523-35. PubMed ID: 11404638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-based payment for HIV/AIDS in Medicaid managed care programs.
    Conviser R; Gamliel S; Honberg L
    Health Care Financ Rev; 1998; 19(3):63-82. PubMed ID: 10345414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment for opioid dependence: quality and access.
    Rounsaville BJ; Kosten TR
    JAMA; 2000 Mar; 283(10):1337-9. PubMed ID: 10714736
    [No Abstract]   [Full Text] [Related]  

  • 32. Medicaid managed care in thirteen states.
    Holahan J; Zuckerman S; Evans A; Rangarajan S
    Health Aff (Millwood); 1998; 17(3):43-63. PubMed ID: 9637966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
    Martin PR; Finlayson AJ
    Am J Drug Alcohol Abuse; 2015; 41(5):367-70. PubMed ID: 26186388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicaid managed care, substance abuse treatment, and people with disabilities: review of the literature.
    Bachman SS; Drainoni ML; Tobias C
    Health Soc Work; 2004 Aug; 29(3):189-96. PubMed ID: 15453057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of maintenance treatment in opioid dependence.
    Ward J; Hall W; Mattick RP
    Lancet; 1999 Jan; 353(9148):221-6. PubMed ID: 9923893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of methadone benefits in the Oregon Health Plan and its effects on patients.
    Fuller BE; Rieckmann TR; McCarty DJ; Ringor-Carty R; Kennard S
    Psychiatr Serv; 2006 May; 57(5):686-91. PubMed ID: 16675764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.
    Weinrich M; Stuart M
    JAMA; 2000 Mar; 283(10):1343-8. PubMed ID: 10714738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicaid managed care and coverage of prescription medications.
    Buchanan RJ
    Am J Public Health; 2002 Aug; 92(8):1238-43. PubMed ID: 12144975
    [No Abstract]   [Full Text] [Related]  

  • 39. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.
    Grogan CM; Andrews C; Abraham A; Humphreys K; Pollack HA; Smith BT; Friedmann PD
    Health Aff (Millwood); 2016 Dec; 35(12):2289-2296. PubMed ID: 27920318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Private Coverage of Methadone in Outpatient Treatment Programs.
    Polsky D; Arsenault S; Azocar F
    Psychiatr Serv; 2020 Mar; 71(3):303-306. PubMed ID: 31822242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.